Glucometabolic-Related Genes as Diagnostic Biomarkers and Therapeutic Targets for Alzheimer’s Disease and Type 2 Diabetes Mellitus: A Bioinformatics Analysis

<div>The Venn map of 41 glucometabolic-related DEGs between Alzheimer’s disease (AD) DEGs, type 2 diabetes mellitus (T2DM) DEGs, and glucometabolic-related genes.</div>

Neurology Research International

fig3

Figure 3

Figure 3: Glucometabolic-Related Genes as Diagnostic Biomarkers and Therapeutic Targets for Alzheimer’s Disease and Type 2 Diabetes Mellitus: A Bioinformatics Analysis 

Figure 3 | Glucometabolic-Related Genes as Diagnostic Biomarkers and Therapeutic Targets for Alzheimer’s Disease and Type 2 Diabetes Mellitus: A Bioinformatics Analysis 